Skip to main content

Histogen Inc.

HSTODelisted Oct 12, 2023
Industry
Pharmaceutical Preparations
SEC CIK
0001383701

Histogen Inc. was delisted on Oct 12, 2023; its insiders filed their last Form 4 on Jun 21, 2023; 9 institutions reported holding it in 13F filings for Q3 2023, worth $9.53K in total; no superinvestor held it.

Holders of 5% or more of HSTO

Holders whose latest Schedule 13D or 13G filing reports 5% or more of Histogen Inc., largest stake first. The change is against the holder's previous filing.

No holder currently reports owning 5% or more of Histogen Inc. on Schedule 13D or 13G.

Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.

13D and 13G filings

6 Schedule 13D and 13G filings on Histogen Inc., newest first, including old-format filings without a stake.

Schedule 13D and 13G filings on HSTO
Filed (ET)FilerFormStakeChangeEvent dateFiling
Feb 14, 2023Armistice Capital, LLC13G/AOld format–––SEC
Feb 8, 2023Intracoastal Capital, LLC13G/AOld format–––SEC
Feb 15, 2022Armistice Capital, LLC13GOld format–New–SEC
Feb 11, 2022Intracoastal Capital, LLC13G/AOld format–––SEC
Jun 16, 2021Intracoastal Capital, LLC13GOld format–––SEC
Jan 8, 2021Intracoastal Capital, LLC13GOld format–New–SEC

Form 144: proposed insider sales

Notices from officers, directors and other affiliates planning to sell Histogen Inc. shares.

No Form 144 notices for Histogen Inc. are on file.